Robert Conway E.'s Insider Trades & SAST Disclosures
Robert Conway E.'s most recent trade in Alpine Immune Sciences Inc was a trade of 50,000 Common Stock done . Disclosure was reported to the exchange on May 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Conway E..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 50,000 | 0 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 17,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 3,075 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 2,868 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 1,912 | 0 | - | - | Stock Option (Right to buy) | |
| Oruka Therapeutics Inc. | Robert Conway E. | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Alpine Immune Sciences Inc | E. Robert Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Purchase of securities on an exchange or from another person at price $ 10.08 per share. | 23 Sep 2021 | 15,000 | 50,000 (0%) | 0% | 10.1 | 151,154 | Common Stock |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Purchase of securities on an exchange or from another person at price $ 9.80 per share. | 21 Sep 2021 | 10,000 | 35,000 (0%) | 0% | 9.8 | 97,966 | Common Stock |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 13 May 2021 | 10,000 | 50,000 (3%) | 0% | 3.2 | 31,947 | Common Stock |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 05 May 2021 | 10,000 | 40,000 (2%) | 0% | 3.2 | 32,345 | Common Stock |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 7,650 | 7,650 | - | - | Stock Option (Right to buy) | |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.16 per share. | 18 Dec 2020 | 10,000 | 30,000 (1%) | 0% | 4.2 | 41,630 | Common Stock |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Purchase of securities on an exchange or from another person at price $ 8.03 per share. | 19 Nov 2020 | 10,000 | 25,000 (0%) | 0% | 8.0 | 80,300 | Common Stock |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.28 per share. | 25 Sep 2020 | 5,000 | 20,000 (1%) | 0% | 4.3 | 21,400 | Common Stock |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.66 per share. | 22 Sep 2020 | 3,056 | 15,000 (0%) | 0% | 4.7 | 14,241 | Common Stock |
| Oruka Therapeutics Inc. | Robert E. Conway | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.77 per share. | 21 Sep 2020 | 10,000 | 11,944 (0%) | 0% | 4.8 | 47,660 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges